699 related articles for article (PubMed ID: 10713699)
1. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
2. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
3. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
[TBL] [Abstract][Full Text] [Related]
4. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
[TBL] [Abstract][Full Text] [Related]
5. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.
Beg AA; Baldwin AS
Oncogene; 1994 May; 9(5):1487-92. PubMed ID: 8152812
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
7. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
8. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells.
Dejardin E; Bonizzi G; Bellahcène A; Castronovo V; Merville MP; Bours V
Oncogene; 1995 Nov; 11(9):1835-41. PubMed ID: 7478612
[TBL] [Abstract][Full Text] [Related]
9. Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ.
Feuillard J; Körner M; Israel A; Vassy J; Raphael M
Eur J Immunol; 1996 Nov; 26(11):2547-51. PubMed ID: 8921937
[TBL] [Abstract][Full Text] [Related]
10. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
[TBL] [Abstract][Full Text] [Related]
13. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
Thornburg NJ; Pathmanathan R; Raab-Traub N
Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
[TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis.
Budunova IV; Perez P; Vaden VR; Spiegelman VS; Slaga TJ; Jorcano JL
Oncogene; 1999 Dec; 18(52):7423-31. PubMed ID: 10602501
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Rel-A and c-Rel protein complexes are differentially distributed within human thymocytes.
Feuillard J; Dargemont C; Ferreira V; Tarantino N; Debré P; Raphael M; Körner M
J Immunol; 1997 Mar; 158(6):2585-91. PubMed ID: 9058790
[TBL] [Abstract][Full Text] [Related]
17. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors.
Naumann M; Nieters A; Hatada EN; Scheidereit C
Oncogene; 1993 Aug; 8(8):2275-81. PubMed ID: 8336950
[TBL] [Abstract][Full Text] [Related]
18. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.
Whiteside ST; Epinat JC; Rice NR; Israël A
EMBO J; 1997 Mar; 16(6):1413-26. PubMed ID: 9135156
[TBL] [Abstract][Full Text] [Related]
19. Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization.
Quinlan KL; Naik SM; Cannon G; Armstrong CA; Bunnett NW; Ansel JC; Caughman SW
J Immunol; 1999 Nov; 163(10):5656-65. PubMed ID: 10553096
[TBL] [Abstract][Full Text] [Related]
20. Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription.
Suzuki T; Hirai H; Yoshida M
Oncogene; 1994 Nov; 9(11):3099-105. PubMed ID: 7936632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]